Amir M. Khan

Sports Medicine | Orthopedics

815 Ira E. Woods Ave
Ste 100
Grapevine, TX 76051

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Efficacy and safety of proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors, alirocumab and evolocumab, a post-commercialization study.

Efficacy and safety of proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors, alirocumab and evolocumab, a post-commercialization study.

Journal: Lipids in health and disease

Published: April 06, 2017

Showing 1-1 of 1

Last Updated: 09/26/2026